The trademark ENACURA was filed by Wilhelm Hoflehner, a national of the Republic of Austria (the "Applicant"). The application was published for oppositions on February 28, 2012, and received undefined oppositions.
There are undefined Oppositions claimed against trademark.
The first opposition filed on May 23, 2012 by Nordic Drugs AB on (a) Likelihood of confusion, (b) Unfair advantage and detriment to distinctiveness or repute. the opponent was represented by SETTERWALLS and its proceedings were handled in English The second opposition filed on May 17, 2012 by Dermapharm AG on Likelihood of confusion. the opponent was represented by DR. KUNZ-HALLSTEIN RECHTSANWÄLTE and its proceedings were handled in German
The application was filed in German, and German was also language of all opposition proceedings (English was selected as the second language).
The renewal of the trademark was recorded by the office on October 6, 2021.
Appointment and Replacement of representative of the trademark registration was recorded on March 26, 2015.
The Appeal with reference B R1321/2013-1 was Trade mark application allowed according to Rule 94 CTMIR with decision issued on September 4, 2014 by the EUIPO. The Opposition with reference B 002019738 was rejected according to Article 8(1)(b) CTMR with decision issued on May 16, 2013 by the EUIPO. The Opposition with reference B 002023771 was partially refused EUTMA/IR according to Article 8(1)(b) CTMR with decision issued on June 27, 2013 by the EUIPO.